Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ivonescimab
Fierce Pharma
Obesity meds, China drive $2T in projected 2032 drug sales: report
Together, drugs tackling obesity and inflammatory conditions are expected to push global pharmaceutical sales above $2 trillion in 2032, per Evaluate.
Fraiser Kansteiner
Jun 23, 2026 9:00am
Fierce Pharma
ASCO: Merck, Kelun's sac-TMT combo beats Keytruda by 65% on PFS
May 21, 2026 5:00pm
Fierce Pharma
Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC
Oct 19, 2025 10:45am
Fierce Pharma
Editor's Corner—Summit must submit to Big Pharma, stat
Sep 10, 2025 2:50pm
Fierce Pharma
Summit's global PD-1xVEGF data show new promising OS trend
Sep 7, 2025 3:30am
Fierce Pharma
Akeso, Summit's PD-1xVEGF drug meets OS goal for the first time
Aug 26, 2025 11:36am